Cancer cell metabolism as new targets for novel designed therapies
about
Identification of extracellular matrix protein 1 as a potential plasma biomarker of ESCC by proteomic analysis using iTRAQ and 2D-LC-MS/MS.Insulin-like growth factor 1 signaling is essential for mitochondrial biogenesis and mitophagy in cancer cells.Model-driven discovery of long-chain fatty acid metabolic reprogramming in heterogeneous prostate cancer cells.From the Cover: Inhibitors of Nicotinamide Phosphoribosyltransferase Cause Retinal Damage in Larval Zebrafish.
P2860
Cancer cell metabolism as new targets for novel designed therapies
description
article
@en
wetenschappelijk artikel
@nl
наукова стаття, опублікована в жовтні 2014
@uk
name
Cancer cell metabolism as new targets for novel designed therapies
@en
Cancer cell metabolism as new targets for novel designed therapies
@nl
type
label
Cancer cell metabolism as new targets for novel designed therapies
@en
Cancer cell metabolism as new targets for novel designed therapies
@nl
prefLabel
Cancer cell metabolism as new targets for novel designed therapies
@en
Cancer cell metabolism as new targets for novel designed therapies
@nl
P2093
P2860
P50
P356
P1476
Cancer cell metabolism as new targets for novel designed therapies
@en
P2093
Anusha Jayaraman
Enric Milà
Esther Aguilar
Ibrahim H Polat
Igor Marín de Mas
Josep J Centelles
Rohit Bharat
P2860
P304
P356
10.4155/FMC.14.119
P577
2014-10-01T00:00:00Z